📰 Practice Guidelines News
Page 4 - Practice Guidelines News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Practice Guidelines. Real-time updates on events, politics, business and more.
April 6, 2024
Based on three Phase II trials of AstraZeneca and Daiichi Sankyos Enhertu which showed clinically meaningful responses across a broad range of tumours ...
April 5, 2024
This clinical quiz will test your knowledge of iron deficiency anemia, focused on the gastrointestinal evaluation of anemia based on recommendations from the AGA's 2020 guidelines.
April 4, 2024
Investigations by the Medical Examiners Commission and Florida Department of Law Enforcement found no evidence of wrongdoing by the medical examiner.
April 2, 2024
— NDA accepted and both fruquintinib and sintilimab granted Priority Review, following Breakthrough Therapy designation in July 2023 — — First regulatory filing for fruquintinib for use in...
April 2, 2024
Background: The overall goal of this report is to provide a high-level, practical approach to managing venous outflow obstruction (VOO). Methods: A group of vascular surgeons from Australia and New Zealand with specific interest, training, and experience in the management of VOO were surveyed to assess current local practices. The results were analyzed and areas of disagreement identified. After this, the group performed a literature review of consensus guidelines published by leading internatio...
April 2, 2024
Ibrutinib has been selected for Medicare price negotiation under the Inflation Reduction Act. The authors summarize the House Oversight Committee investigation to be considered by CMS during the price negotiation process.
April 2, 2024
A new study found that adults in custody of the Federal Bureau of Prisons have seen improved pre-exposure prophylaxis (PrEP) initiation and sustained treatment uptake for HIV.
March 26, 2024
There are concerns that teens on 7 Cups are being targeted by predators.
March 9, 2024
The burst of translational research leading to PARP inhibitors in prostate cancer, along with imaging and diagnostic advances, has been a monumental evolution for the management of this disease.